Skip to Main Content
our new site.
NLM Technical Bulletin
Full Text View
No Study Results Posted
Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts (ONTIME)
This study is ongoing, but not recruiting participants.
Study NCT01241500 Information provided by Onconova Therapeutics, Inc.
First Received on November 1, 2010. Last Updated on February 3, 2014
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Chronic Myelomonocytic Leukemia
Additional conditions recognized in this trial
Leukemia, Myelomonocytic, Acute
Leukemia, Myelomonocytic, Chronic
More general conditions related to this trial
Bone Marrow Diseases
Neoplasms by Histologic Type
Interventions listed in this trial
Sponsors listed in this trial
Onconova Therapeutics, Inc.
The Leukemia and Lymphoma Society
Back to top of Main Content
Contact Help Desk
Lister Hill National Center for Biomedical Communications
U.S. National Library of Medicine
U.S. National Institutes of Health
U.S. Department of Health & Human Services
Freedom of Information Act
Links to all studies - primarily for crawlers